70921-62-9

Usage

Uses

Used in Pharmaceutical Development:
H-ARG-SER-OH-ACETATE SALT is used as a building block for the synthesis of pharmaceutical compounds due to its constituent amino acids, arginine and serine, which are essential in various biological processes.
Used in Chemical Research:
H-ARG-SER-OH-ACETATE SALT is used as a reagent in chemical research for studying the properties and reactions of amino acids and their derivatives.
Used in Biological Research:
H-ARG-SER-OH-ACETATE SALT is used as a component in biological research to investigate the roles of arginine and serine in protein synthesis and other cellular functions.
Used in Biochemical Applications:
H-ARG-SER-OH-ACETATE SALT is used as a precursor in the development of biochemical products, such as enzymes and other proteins, that require these specific amino acids for their structure and function.
Used in Cosmetics Industry:
H-ARG-SER-OH-ACETATE SALT is used as an ingredient in cosmetic formulations for its potential benefits in skin health and regeneration, given the importance of arginine and serine in protein synthesis and cell repair.
Used in Food Industry:
H-ARG-SER-OH-ACETATE SALT may be used in the food industry as a dietary supplement or functional ingredient, capitalizing on the nutritional benefits of arginine and serine for overall health and well-being.

Upstream product

• 56-45-1 L-serin 
• 74-79-3 L-arginine 
• 14611-34-8 N^α,N^δ,N^ω-tris(benzyloxycarbonyl)-L-arginine 
• 102249-13-8 N^α,N^G,N^G-tribenzyloxycarbonylarginyl-(O-benzyl)serine 

Downstream Products

• 102249-11-6 N^α-benzyloxycarbonyltryptophylarginylserine 

Relevant academic research and scientific papers

A novel L-amino acid ligase from Bacillus subtilis NBRC3134, a microorganism producing peptide-antibiotic rhizocticin

L-Amino acid ligase catalyzes the formation of an α-peptide bond from unprotected L-amino acids in an ATP-dependent manner, and this enzyme is very useful in efficient peptide production. We performed enzyme purification to obtain a novel L-amino acid lig

Depigmenting activity of agouti signal protein and peptides thereof

The invention is an agouti signaling protein and peptides as well as pharmaceutical compositions thereof and their use in methods of inhibiting melanin production by melanocytes. The agouti signaling protein and peptides thereof are useful in cosmetics and in clinical prevention and treatment of hyperpigmentary conditions. Methods for screening peptides for melanogenesis inhibiting activity are also provided.

Disulfide bridged cyclic peptides containing a cgridri sequence useful in control of hypertension

Disulfide bridged cyclic peptides are described which are preferably 13 to 20 amino acid residues in length and which include the endocyclic sequence cys-gly-arg-ile-asp-arg-ile. Peptides of this class are selective for and show picomolar-range affinity for the non-guanyl cyclase-coupled atrial peptide receptor. Affinity for this receptor is associated with potentiation of the mean arterial pressure response to atrial peptide and these peptides are therefore useful in control of hypertension. Peptides of most interest are of the formula wherein X1 is the peptidic fragment ser-ser; wherein X2 is a peptidic fragment selected from gly-ser-gly-leu, gly-ala-gly-leu and gly-leu; wherein X3 is the peptidic fragment asn-ser-phe-arg; wherein m is zero or one, n is one and r is one; and wherein A represents an amino terminus or its pharmaceutically--acceptable salt, and B represents a carboxyl terminus or its pharmaceutically-acceptable ester, amide or salt.

Deblocking of peptides with proton donors

A series of model di- and tripeptides were synthesized, and they were deblocked with ammonium formate and cyclohexene in the presence of a palladium catalyst.It was shown that the deblocking of the peptides containing nitroarginine takes place readily and